{"id":262,"date":"2019-07-09T14:06:26","date_gmt":"2019-07-09T14:06:26","guid":{"rendered":"http:\/\/milannetconference.com\/?page_id=262"},"modified":"2019-07-16T13:59:21","modified_gmt":"2019-07-16T13:59:21","slug":"abstract-2019","status":"publish","type":"page","link":"https:\/\/milannetconference.com\/?page_id=262","title":{"rendered":"ABSTRACT 2019"},"content":{"rendered":"

[vc_row][vc_column width=”1\/1″][vc_row_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image media=”259″ media_width_percent=”100″ alignment=”center”][\/vc_column_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][\/vc_row_inner][vc_column_text]<\/p>\n

P<\/strong>r<\/strong>ogr<\/strong>amma<\/strong><\/h1>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″][vc_column_text]08:15-08:45<\/strong>\u00a0 \u00a0 Registration<\/p>\n

08:45-09:00<\/strong>\u00a0 \u00a0Introduction: why and when of an active meeting among Centers<\/p>\n

Session 1: Looking forward NETs<\/h2>\n

Chairs: F. de Braud, V. Mazzaferro<\/h4>\n

Discussants: V. Ambrosini, M. P. Brizzi, M. V. Dav\u00ec, F. Grillo, S. Massironi, S. Partelli<\/strong><\/p>\n

09:00-09:20<\/strong>\u00a0 \u00a0 Circulating tumor cells, DNA and MicroRNAs as prognostic markers for NETs – M. C. Zatelli<\/a><\/p>\n

09:20-09:40<\/strong>\u00a0 \u00a0 Recent update on diagnosis, clinical features and management of MENs – S. Glasberg<\/a><\/p>\n

09:40-10:00<\/strong>\u00a0 \u00a0 Current and future perspectives of radiometabolic therapies for neuroendocrine tumors – A.J.A.T. Braat<\/a><\/p>\n

10:00-10:20<\/strong>\u00a0 \u00a0 PRRT alone or in combination with other drugs? – N. Fazio<\/a><\/p>\n

10:20-10:40<\/strong>\u00a0 \u00a0 Surgery of GEP-NETs in oligometastatic disease – A. Frilling<\/a><\/p>\n

10:40-11:00<\/strong>\u00a0 \u00a0 Post-surgical monitoring of curatively resected GEP-NETs – V. Mazzaferro<\/p>\n

11:00-11:30<\/strong>\u00a0 \u00a0 Coffee break[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″][vc_column_text]<\/p>\n

Session 2: Video Presentation<\/h2>\n

Chairs: A. Frilling, V. Mazzaferro<\/h4>\n

11:30-12:00\u00a0<\/strong> \u00a0 Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for the treatment of pNETs
\nPresenters:\u00a0 \u00a0 \u00a0\u00a0F. Cavalcoli, G. Delconte<\/a><\/strong>
\nDiscussant:\u00a0 \u00a0 \u00a0A. Larghi<\/strong><\/a><\/p>\n

12:00-12:30<\/strong>\u00a0 \u00a0 Radioembolization in syndromic patients with liver metastases refractory to therapy
\nPresenters:\u00a0 \u00a0 \u00a0M. Maccauro, N. Prinzi<\/a>, C. Spreafico<\/strong>
\nDiscussant:\u00a0 \u00a0\u00a0 I. Bargellini<\/strong><\/p>\n

12:30-13:00<\/strong>\u00a0 \u00a0 Indications for laparoscopic pNET resections
\nPresenters:\u00a0 \u00a0 \u00a0\u00a0C. Sposito, M. Virdis<\/strong>
\nDiscussant:\u00a0 \u00a0\u00a0 G. Butturini<\/strong><\/p>\n

13:00-14:00<\/strong>\u00a0 \u00a0 Lunch[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″][vc_column_text]<\/p>\n

Session 3: Web multimodal Tumor Board<\/h2>\n

WEB-CONNECTED CENTERS: Catania, Napoli, Roma e Verona<\/h4>\n

Board coordinators and question makers: N. Fazio, J. Coppa<\/strong><\/p>\n

14:00-15:30\u00a0 \u00a0 Tumor board 1<\/a><\/strong>
\nParticipants: R. Baldelli, C. Cotsoglou, R. Lanocita, M. Milione, S. Pusceddu, E. Seregni, F. Spada<\/strong><\/p>\n

Retroperitoneal pheochromocytoma
\nTherapy-resistant insulinoma
\npNET liver metastases
\nParaneoplastic syndrom in a lung carcinoid<\/p><\/blockquote>\n

15:30-17:00\u00a0 \u00a0 Tumor board 2<\/a><\/strong><\/p>\n

Participants: M. Albertelli, M. Bongini, C. Carnaghi, T. Cascella, M. Milione, S. Pusceddu, F. Scalorbi, A. Versari<\/strong><\/p>\n

PRRT and loco-regional therapies
\nCardias NEC G3
\nAnalogue-based therapies
\nUrogenital NEC G3<\/p><\/blockquote>\n

17:00-17:30\u00a0 \u00a0 Take-home messages and closure<\/strong>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column width=”1\/1″][vc_row_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_single_image media=”259″ media_width_percent=”100″ alignment=”center”][\/vc_column_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][\/vc_row_inner][vc_column_text] Programma [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/1″][vc_column_text]08:15-08:45\u00a0 \u00a0 Registration 08:45-09:00\u00a0 \u00a0Introduction: why and when of an […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/pages\/262"}],"collection":[{"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/milannetconference.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=262"}],"version-history":[{"count":13,"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/pages\/262\/revisions"}],"predecessor-version":[{"id":290,"href":"https:\/\/milannetconference.com\/index.php?rest_route=\/wp\/v2\/pages\/262\/revisions\/290"}],"wp:attachment":[{"href":"https:\/\/milannetconference.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}